Home » Topics » Disease categories and therapies » Infection

Infection
RSS

StressGen begins second phase I safety trial of HspE7

July 15, 1999

Abgenix and U.S. Army to cooperate on antibody-based defenses against filoviruses

July 15, 1999

Broad-spectrum antivirals with heterocyclic structure developed at BioChem Pharma

July 14, 1999

WHO develops pyronaridine, an orally active agent for treating chloroquine-resistant malaria

July 13, 1999

Bristol-Myers Squibb extends antiinfective collaboration with Cubist Pharmaceuticals

July 13, 1999

Zanamivir shows promise in influenza prevention

July 12, 1999

Vancomycin-tolerant S. pneumoniae detected and analyzed

July 12, 1999

Chinese herbal medicine demonstrates high efficacy against influenza in mice

July 9, 1999

Oral mucositis prevention with IB-367 assessed

July 9, 1999

Demegen peptides active against multidrug-resistant bacteria

July 6, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Novartis to pay $1.5B for Myricx Bio and its novel ADC payloads
BioWorld
Novartis AG is to pay $1.1 billion up front to acquire Myricx Bio Ltd., a preclinical-stage antibody-drug conjugate (ADC) specialist that is advancing a novel and...